|
|
Article: Teva Releases Fexofenadine HCl and Pseudoephedrine HCl Extended-Release Tablets.
- Article from:
- Health & Beauty Close-Up
- Article date:
- November 6, 2009
CopyrightCOPYRIGHT 2009 Close-Up Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Teva Pharmaceutical Industries has announced the commercial launch of Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets, the same as the sanofi-aventis U.S. allergy treatment Allegra-D 12 Hour (fexofenadine HCl 60 mg and pseudoephedrine HCl 120 mg) Extended-Release Tablets.
Teva' said that its product is an alternative to the brand product, which had annual sales of approximately $293 million in the United States for the twelve months that ended June 30, based on IMS sales data.
As the ...